Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Bio-Rad financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.

Stock Price

$350.5

2024-03-22

Market Capitalization

$9.9 B

2024-03-22

Revenue

$2.7 B

FY, 2023

CreditSafe Score

?
Score changed on Apr 19, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2020FY, 2021FY, 2022FY, 2023
Revenue2.5B2.9B2.8B2.7B
Revenue growth, %10.1%14.8%
Cost of goods sold1.1B1.3B1.2B1.2B
Gross profit1.4B1.6B1.6B1.4B
Gross profit margin, %56.5%56.1%55.9%53.4%
General and administrative expense800.3M879.6M827.8M841.7M
Operating expense total1.0B1.2B1.1B1.1B
EBIT411.0M489.4M482.6M337.8M
EBIT margin, %16.1%16.7%17.2%12.6%
Investment income100.9M
Interest income100.9M
Interest expense21.9M1.6M38.1M49.4M
Pre tax profit4.9B5.4B(4.7B)(850.1M)
Income tax expense1.1B1.2B(1.1B)(212.8M)
Net Income3.8B4.2B(3.6B)(637.3M)
EPS126.2140.6(121.8)(21.8)

Acquisitions & Subsidiaries

Company nameDateDeal size
LoremDec 23, 2021$40.0M
IpsumJan 18, 2022$30.0M
Lorem IpsumFeb 18, 2022$25.0M
DolorOct 21, 2021$60.0M
Premium Content only available in Craft’s Intelligence Portal
View acquisitions and subsidiaries by company, date, and deal size.
Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm.
Learn more

Footer menu